Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
3.320
-0.070 (-2.06%)
Oct 24, 2024, 4:00 PM EDT - Market closed

Affimed Revenue

Affimed had revenue of 210.00K EUR in the quarter ending June 30, 2024, a decrease of -90.03%. This brings the company's revenue in the last twelve months to 7.43M, down -78.06% year-over-year. In the year 2023, Affimed had annual revenue of 13.91M, down -67.39%.

Revenue (ttm)
7.43M EUR
Revenue Growth
-78.06%
P/S Ratio
6.42
Revenue / Employee
97,750 EUR
Employees
76
Market Cap
52.06M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.91M-28.76M-67.39%
Dec 31, 202242.67M1.12M2.70%
Dec 31, 202141.55M12.69M43.99%
Dec 31, 202028.86M7.43M34.66%
Dec 31, 201921.43M-2.30M-9.68%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Atara Biotherapeutics 62.39M
Cytosorbents 37.16M
Qilian International Holding Group 29.87M
SCYNEXIS 9.67M
Kronos Bio 8.41M
Kezar Life Sciences 7.00M
OncoCyte 1.02M
Envoy Medical 302.00K
Revenue Rankings